-
Je něco špatně v tomto záznamu ?
Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis
L. Sromova, H. Mareckova, L. Sedova, E. Balaziova, A. Sedo,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NR9273
MZ0
CEP - Centrální evidence projektů
- MeSH
- buněčná membrána enzymologie MeSH
- dipeptidylpeptidasa 4 chemie metabolismus MeSH
- leukocyty mononukleární cytologie enzymologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- membránové proteiny metabolismus MeSH
- osteoartróza enzymologie MeSH
- revmatoidní artritida krev enzymologie MeSH
- rozpustnost MeSH
- serinové endopeptidasy metabolismus MeSH
- synoviální tekutina enzymologie MeSH
- želatinasy metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Dipeptidyl peptidase-IV (DPP-IV) enzymatic activity controls biological halftime of multiple local mediators. Its deregulation is associated with pathogenesis of several autoimmune diseases, including rheumatoid arthritis (RA). Although DPP-IV is the canonical representative of the group, a number of other proteins have been shown to have similar enzymatic activity. This study was aimed to identify the molecular source of DPP-IV activity in synovial fluid (SF) and fluid mononuclear cells (FMNC) in patients with RA and osteoarthritis (OA). In addition, the association of DPP-IV and the concentration of stromal cell-derived factor-1alpha (SDF), DPP-IV substrate, were evaluated. METHODS: DPP-IV activity was measured by the kinetic fluorimetric method. The expression of studied molecules in FMNC and their concentrations in SF were assayed using flow cytometry and ELISA respectively. RESULTS: DPP-IV activity in SF, dominantly derived from the canonical DPP-IV, does not significantly differ between RA and OA. However, a significantly lower DPP-IV activity and expression in FMNC was found in RA as opposed to OA patients. Negative correlation between SDF concentration in SF and the relative amount of CD3+CD26+ cells was observed. CONCLUSIONS: We report decreased presence of DPP-IV/CD26 in CD3+ FMNC in RA, which also may participate on impaired balance of SDF concentration in SF.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025823
- 003
- CZ-PrNML
- 005
- 20170321090443.0
- 007
- ta
- 008
- 120817s2010 ne f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cca.2010.03.034 $2 doi
- 035 __
- $a (PubMed)20361950
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Stollinová Šromová, Lucie $7 xx0211880 $u Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Czech Republic
- 245 10
- $a Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis / $c L. Sromova, H. Mareckova, L. Sedova, E. Balaziova, A. Sedo,
- 520 9_
- $a BACKGROUND: Dipeptidyl peptidase-IV (DPP-IV) enzymatic activity controls biological halftime of multiple local mediators. Its deregulation is associated with pathogenesis of several autoimmune diseases, including rheumatoid arthritis (RA). Although DPP-IV is the canonical representative of the group, a number of other proteins have been shown to have similar enzymatic activity. This study was aimed to identify the molecular source of DPP-IV activity in synovial fluid (SF) and fluid mononuclear cells (FMNC) in patients with RA and osteoarthritis (OA). In addition, the association of DPP-IV and the concentration of stromal cell-derived factor-1alpha (SDF), DPP-IV substrate, were evaluated. METHODS: DPP-IV activity was measured by the kinetic fluorimetric method. The expression of studied molecules in FMNC and their concentrations in SF were assayed using flow cytometry and ELISA respectively. RESULTS: DPP-IV activity in SF, dominantly derived from the canonical DPP-IV, does not significantly differ between RA and OA. However, a significantly lower DPP-IV activity and expression in FMNC was found in RA as opposed to OA patients. Negative correlation between SDF concentration in SF and the relative amount of CD3+CD26+ cells was observed. CONCLUSIONS: We report decreased presence of DPP-IV/CD26 in CD3+ FMNC in RA, which also may participate on impaired balance of SDF concentration in SF.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a revmatoidní artritida $x krev $x enzymologie $7 D001172
- 650 _2
- $a buněčná membrána $x enzymologie $7 D002462
- 650 _2
- $a dipeptidylpeptidasa 4 $x chemie $x metabolismus $7 D018819
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a želatinasy $x metabolismus $7 D018093
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leukocyty mononukleární $x cytologie $x enzymologie $7 D007963
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránové proteiny $x metabolismus $7 D008565
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a osteoartróza $x enzymologie $7 D010003
- 650 _2
- $a serinové endopeptidasy $x metabolismus $7 D012697
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a synoviální tekutina $x enzymologie $7 D013582
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Posová, Helena, $d 1963- $7 xx0060265 $u Institute of Immunology and Microbiology of the First Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Šedová, Liliana $7 xx0054446 $u Institute of Rheumatology, Prague, Czech Republic
- 700 1_
- $a Balážiová, Eva $7 xx0126036 $u Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Šedo, Aleksi, $d 1967- $7 jn20000605245 $u Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Czech Republic
- 773 0_
- $w MED00009464 $t Clinica chimica acta; international journal of clinical chemistry $x 1873-3492 $g Roč. 411, č. 15-16 (2010), s. 1046-1050
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20361950 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20170321090714 $b ABA008
- 999 __
- $a ok $b bmc $g 947865 $s 783169
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 411 $c 15-16 $d 1046-1050 $e 20100331 $i 1873-3492 $m Clinica chimica acta $n Clin Chim Acta $x MED00009464
- GRA __
- $a NR9273 $p MZ0
- LZP __
- $a Pubmed-20120817/10/03